Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet

Affiliations

• ¹ Department of Medicine, Duke Cancer Institute, Durham, New York, USA.
• ² Department of Oncology, Johns Hopkins University, Baltimore, USA.
• ³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
• ⁴ Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA.
• ⁵ Department of Medicine, Weill Cornell Medical College, New York, USA.
• ⁶ Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
• ⁷ Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA.
• ⁸ Carolina Urologic Research Center, Myrtle Beach, USA.
• ⁹ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
• ¹⁰ Weill Cornell Medical College, New York, USA.
• ¹¹ Department of Medicine, MD Anderson Cancer Center, Houston, USA.
• ¹² School of Medicine, University of Virginia, Charlottesville, USA.
• ¹³ Division of Hematology/Oncology, Wayne State University, Detroit, USA.
• ¹⁴ Division of Hematology/Oncology, University of Wisconsin, Madison, USA.
• ¹⁵ Department of Medicine, Rutgers Cancer Institute of New Jersey, Newark, USA.
• ¹⁶ Massachusetts General Hospital, Cancer Center, Boston, USA.
• ¹⁷ Department of Medical Oncology, San Camillo-Forlanini Hospital, Rome, Italy.
• ¹⁸ Division of Human Biology, University of Washington, Seattle, USA.
• ¹⁹ Fred Hutchinson Cancer Center, Seattle, USA.
• ²⁰ Department of Urology, The Christie Clinic, National Health Service, Manchester, UK.
• ²¹ Department of Urology, UC Davis, Sacramento, USA.
• ²² Department of Oncology, University Hospital Aschen, Cologne, Germany.
• ²³ Department of Urology, University Hospital St. Etienne, Saint-Etienne, France.
• ²⁴ Department of Urologic Sciences, Vancouver Prostate Centre, Vancouver, Canada.